G-Actin Cleavage Parallels 2-5A-Dependent RNase L Cleavage in Peripheral Blood Mononuclear Cells—Relevance to a Possible Serum-Based Screening Test for Dysregulations in the 2-5A Pathway

Journal of Chronic Fatigue Syndrome

Volumn 8, Issue 42067, 2001, Pages 63-82

  Roelens, Simon ^a   Herst, C Vincent ^a   d'haese, Anne ^a   de Smet, Karen ^a   Frémont, Marc ^a   de Meirleir, Kenny ^b   Englebienne, Patrick ^a,c  

^a R E D LABORATORIES   (Belgium)

^b VRIJE UNIVERSITEIT BRUSSEL   (Belgium)

^c UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

Author keywords

2 5A pathway; 37 kDa 2 5A binding protein; apoptosis; calpain; CFS; chronic fatigue syndrome; G Actin; PBMC; RNase L; serum screening test

Indexed keywords

2',5' OLIGOADENYLIC ACID; CALPAIN; CASPASE 3; G ACTIN; RIBONUCLEASE; RIBONUCLEASE L; UNCLASSIFIED DRUG;

CHRONIC FATIGUE SYNDROME; CONFERENCE PAPER; CONTROLLED STUDY; ENZYME ACTIVITY; HUMAN; HUMAN CELL; IMMUNOBLOTTING; MOLECULAR WEIGHT; MONONUCLEAR CELL; PROTEIN DEGRADATION; SCREENING TEST;

EID: 0035660239     PISSN: 10573321     EISSN: 15470660     Source Type: Journal    
DOI: 10.1300/J092v08n03_07     Document Type: Article

References (32)

1. Williams BRG, Golgher RR, Brown RE, et al. Natural occurrence of 2-5A in in-terferon-treated EMC virus-infected L cells. Nature 1979; 282: 582 – 586.
2. Maitra RK, Li G, Xiao W, et al. Catalytic cleavage of an RNA target by 2-5A antisense and R Nase L. J. Biol. Chem. 1995; 270: 15071 – 15075.
3. Dong B, Silverman RH. 2-5A-dependent R Nase molecules dimerize during ac-tivation by 2-5A. J. Biol. Chem. 1995; 270: 4133 – 4137.
4. Wreschner DH, McCauley JW, Skehel JJ, et al. Interferon action—Sequence specificity of the ppp(A2'p). A-dependent ribonuclease. Nature 1981; 289: 414 – 417.
5. Komaroff AL, Buchwald DS. Chronic fatigue syndrome: An update. Annu. Rev. Med. 1998; 49: 1 – 13.
6. Konstantinov K, Von Miekecz A, Buchwald D, et al. Autoantibodies to nuclear envelope antigens in chronic fatigue syndrome. J. ClM. Invest. 1996; 98: 1888 – 1896.
7. Landay AL, Jessop C, Lennette ET, et al. Chronic fatigue syndrome: Condition associated with immune activation. Lancet 1991; 338: 707 – 712.
8. Strauss SE, Komaroff AL, Wedner HJ. Chronic fatigue syndrome: Point and counterpoint. J. Infect. Dis. 1994; 170: 1 – 6.
9. Swanink CMA., Vercoulen JHMM., Bleijenberg G., et al. Chronic fatigue syn-drome: A clinical and laboratory study with a well matched control group. J. Intern. Med. 1995; 237: 499 – 506.
10. Visser J, Blauw B, Hinloopen B, et al. CD4 T Lymphocytes from patients with chronic fatigue syndrome have decreased interferon-y production and increased sensi-tivity to dexamethasone. J. Infect. Dis. 1998; 177: 451 – 454.
11. Suhadolnik RJ, Reichenbach NL, Hitzges P, et al. Upregulation of the 2-5A synthetase/R Nase L antiviral pathway associated with chronic fatigue syndrome. ClM. Infect. Dis. 1994; 18: S96–S 104.
12. Suhadolnik RJ, Reichenbach NL, Hitzges P, et al. Changes in the 2-5A synthetase/R Nase L antiviral pathway in a controlled clinical trial with Poly(I)-Poly(C12U) in chronic fatigue syndrome. In Vivo 1994; 8: 599 – 604.
13. Suhadolnik RJ, Peterson DL, O'Brien K, et al. Biochemical evidence for a novel low molecular weight 2-5A-dependent R Nase L in chronic fatigue syndrome. J. Interferon Cytokine Res. 1997; 17: 377 – 385.
14. De Meirleir K, Bisbal C, Campine I, et al. A 37 kDa 2-5A binding protein as a potential biochemical marker for chronic fatigue syndrome. Am. J. Med. 2000; 108: 99 – 105.
15. Vojdani A, Ghoneum M, Choppa PC, et al. Elevated apoptotic cell population in patients with chronic fatigue syndrome: The pivotal role of protein kinase RNA. J. In-tern. Med. 1997; 242: 465 – 478.
16. Coue M, Constans J, Olomucki A. Effects of serum vitamin-D-binding protein on actin in the presence of plasma gelsolin. Eur. J. Biochem. 1986; 160: 273 – 277.
17. Zhou A, Hassel BA, Silverman RH. Expression cloning of 2-5A-dependent RN Aase: A uniquely regulated mediator of interferon action. Cell 1993; 72: 753 – 765.
18. Earnshaw WC, Martins LM, Kaufmann SH. Mammalian caspases: Structure, activation, substrates, and functions during apoptosis. Annu. Rev. Biochem. 1999; 68: 383 – 424.
19. Saido TC, Sorimachi H, Suzuki K. Calpain: New perspectives in molecular di-versity and physiological-pathological involvement. FASEB J. 1994; 8: 814 – 822.
20. Mashima T, Naito M, Tsuruo T. Caspase-mediated cleavage of cytoskeletal actin plays a positive role in the process of morphological apoptosis. Oncogene 1999; 18: 2423 – 2430.
21. Goldschmidt-Clermont P, Allen RC, Nel AE, et al. Gc (vitamin D-binding pro-tein) binds the 33.5 K tryptic fragment of actin. Life Sci. 1986; 38: 735 – 742.
22. Mc Leod JF, Kowalski MA, Haddad JG. Jr Interactions among serum vitamin D binding protein, monomeric actin, profilin and profilactin. J. Biol. Chem. 1989; 264: 1260 – 1267.
23. Diaz-Guerra M, Rivas C, Esteban M. Activation of the IFN-inducible enzyme R Nase L causes apoptosis of animal cells. Virology 1997; 236: 354 – 363.
24. Caste Ili JC, Hassel BA, Wood KA, et al. A study of the interferon antiviral mechanism: Apoptosis activation by the 2-5A system. J. Exp. Med. 1997; 186: 967 – 972.
25. Villa G, Henzel WJ, Sensenbrenner M, et al. Calpain inhibitors, but not caspase inhibitors, prevent actin proteolysis and DNA fragmentation during apoptosis. J. Cell Sci. 1998; 111: 713 – 722.
26. Brown SB, Bailey K, Savill J. Actin is cleaved during constitutive apoptosis. Biochem. J. 1997; 323: 233 – 237.
27. Mashima T, Naito M, Noguchi K, et al. Actin cleavage by CPP32/apopain dur-ing the development of apoptosis. Oncogene 1997; 14: 1007 – 1012.
28. Song Q, Wei T, Lees-Miller S, et al. Resistance of actin to cleavage during apoptosis. Proc. Nat. Acad. Sci. USA 1997; 94: 157 – 162.
29. Dustin ML, Cooper JA. The immunological synapse and the actin cytoskeleton: Molecular hardware for T cell signaling. Nature Immunol. 2000; 1: 23 – 29.
30. Komaroff AL. The biology of chronic fatigue syndrome. Am. J. Med. 2000; 108: 169 – 171.
31. Goldschmidt-Clermont PJ, Galbraith RM, Emerson DL, et al. Accurate quanti-tation of native Gc in serum and estimation of endogenous Gc:G-actin complexes by rocket immunoelectrophoresis. Clin. Chim. Acta 1985; 148: 173 – 183.
32. Young WO, Goldschmidt-Clermont P, Emerson DL, et al. Correlation between extent of liver damage in fulminant hepatic necrosis and complexing of circulating group-specific component (vitamin D-binding protein). J. Lab. Clin. Med. 1987; 110: 83 – 90.